By Kirsty Oswald, medwireNews Reporter
Research using RNA interference (RNAi)-based screening has identified several potential targets for the treatment of malignant pleural mesothelioma (MPM).
The study authors, led by Glen Reid of the University of Sydney in New South Wales, Australia, say…
RNAi-based screening offers MPM treatment hope
Friday, January 31, 2014
RNAi-based screening offers MPM treatment hope
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment